نتایج جستجو برای: prothrombin complex concentrates

تعداد نتایج: 799368  

2013
Freeha Arshad Brigitte Ickx Rachel T van Beem Wojciech Polak Frank Grüne Frederik Nevens Minna Ilmakunnas Anna-Maria Koivusalo Helena Isoniemi Paul FW Strengers Henk Groen Herman GD Hendriks Ton Lisman Jacques Pirenne Robert J Porte

BACKGROUND In patients with cirrhosis, the synthesis of coagulation factors can fall short, reflected by a prolonged prothrombin time. Although anticoagulants factors are decreased as well, blood loss during orthotopic liver transplantation can still be excessive. Blood loss during orthotopic liver transplantation is currently managed by transfusion of red blood cell concentrates, platelet conc...

Journal: :Thrombosis and haemostasis 2007
Helmut Ostermann Sabine Haertel Sigurd Knaub Uwe Kalina Kerstin Jung Ingrid Pabinger

Prothrombin complex concentrates (PCCs) are widely administered for emergency oral anticoagulation reversal and for coagulation defects in liver disease. Pharmacokinetic data may help to optimize treatment. The objective of this study was to characterize the pharmacokinetics of a PCC (Beriplex P/N) containing coagulation factors II (FII), VII (FVII), IX (FIX) and X (FX) and anticoagulant protei...

  Background: Factor VII concentrates are used in patients with congenital or acquired factor VII deficiency or treatment of hemophilia patients with inhibitors. In this research, immunoaffinity chromatography was used to purify factor VII from prothrombin complex (Prothrombin-Proconvertin-Stuart Factor-Antihemophilic Factor B or PPSB) which contains coagulation factors II, VII, IX and X. The a...

2013
Gines Escolar Victor Fernandez-Gallego Eduardo Arellano-Rodrigo Jaume Roquer Joan Carles Reverter Victoria Veronica Sanz Patricia Molina Irene Lopez-Vilchez Maribel Diaz-Ricart Ana Maria Galan

Apixaban is a new oral anticoagulant with a specific inhibitory action on FXa. No information is available on the reversal of the antihemostatic action of apixaban in experimental or clinical settings. We have evaluated the effectiveness of different factor concentrates at reversing modifications of hemostatic mechanisms induced by moderately elevated concentrations of apixaban (200 ng/ml) adde...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید